“We’re expanding the paradigm of how to do clinical studies.”   Kimlin Tam Ashing, Ph.D., is speaking excitedly about a new clinical trial that’s breaking some old norms in order to...

Michael Rosenzweig, M.D., M.S. You may never have heard of a disease called amyloidosis. It’s classified as rare, and very few physicians specialize in it. City of Hope hematologist...

Last fall, City of Hope scientists opened a clinical trial investigating the use of the arthritis drug leflunomide as an innovative treatment for cancer patients with COVID-19. Now, thanks to a...